Princeton Global Asset Management LLC Gilead Sciences, Inc. Transaction History
Princeton Global Asset Management LLC
- $474 Million
- Q1 2025
A detailed history of Princeton Global Asset Management LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Princeton Global Asset Management LLC holds 500 shares of GILD stock, worth $51,585. This represents 0.01% of its overall portfolio holdings.
Number of Shares
500
Previous 500
-0.0%
Holding current value
$51,585
Previous $46,000
21.74%
% of portfolio
0.01%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding GILD
# of Institutions
2,146Shares Held
988MCall Options Held
8.73MPut Options Held
9.63M-
Black Rock Inc. New York, NY121MShares$12.4 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA116MShares$11.9 Billion0.19% of portfolio
-
Capital World Investors Los Angeles, CA71.7MShares$7.4 Billion1.05% of portfolio
-
State Street Corp Boston, MA60.4MShares$6.23 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.9MShares$5.98 Billion1.15% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $129B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...